Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Aspasia Bastard-Stamatoullas

Long-Term Results and Competing Risk Analysis of the H89 Trial in Patients With Advanced-Stage Hodgkin Lymphoma: A Study by the Groupe d'Etude Des Lymphomes De l'Adulte (GELA)

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Related publications

Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Long-Term Quality of Life in Patients With Advanced Hodgkin Lymphoma: A Systematic Review

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Lymphomes. Lymphomes Non Hodgkiniens — Maladie De Hodgkin

Acta Endoscopica
Nuclear MedicineRadiologyImaging
1998English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

UPDATED SAFETY AND EFFICACY RESULTS OF «HLMoscow 1-3» STUDY FOR THE 147 UNTREATED PATIENTS WITH ADVANCED CLASSICAL HODGKIN LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Transcriptional Networks Associated With Treatment Failure in Advanced-Stage Hodgkin Lymphoma: Data From the Rathl Trial (Cruk/07/033)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Adrenal Involvement in MEN1. Analysis of 715 Cases From the Groupe d'Etude Des Tumeurs Endocrines Database

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Interim FDG-PET Does Not Predict Outcome in Advanced-Stage Hodgkin Lymphoma Patients Treated With BEACOPP

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy